中财网 中财网股票行情
恩华药业(002262)财务分析指标    年份：
截止日期2025-03-312024-12-312024-09-302024-06-302024-03-31
营业总收入(万元)151088.88569763.30414546.31276339.81135756.57
营业收入(万元)151088.88569763.30414546.31276339.81135756.57
营业总成本(万元)119639.55447751.62302427.18203408.29106692.73
营业成本(万元)38239.43150654.09108807.2675996.7139670.69
净利润(万元)30070.57113768.33102010.7162892.0326528.22
归属于母公司的净利润(万元)30070.57114356.44102010.7162892.0326528.22
营业利润(万元)33860.21133657.36117139.3473255.3830487.13
利润总额(万元)33633.12129668.84115239.8372099.2529973.61
少数股东损益(万元)-6.61-277.21-356.99-234.67-64.35
基本每股收益(元)0.30(元)1.13(元)1.01(元)0.62(元)0.26(元)
稀释每股收益(元)0.30(元)1.13(元)1.01(元)0.62(元)0.26(元)
非经常性损益(万元)87.381.95-1035.67---200.41
扣除非经常性损益后净利润(万元)29983.19114354.49103046.3863397.5226728.64
总资产(万元)886902.34844000.57812890.88764239.03760395.48
总负债(万元)127627.65116648.99102469.2192813.7392920.84
归属于母公司股东权益合计(万元)761961.89730032.17713182.04674063.36669942.37
股东权益合计(万元)759274.69727351.58710421.67671425.30667474.64
实收资本(股本)(万元)101617.68101617.68101617.68100758.81100758.81
资本公积(万元)26276.9724417.8219325.3010298.5810298.58
未分配利润(万元)593056.68562986.10551069.81511951.12507830.14
经营活动产生的现金流量净额(万元)31927.2391612.6591119.2762183.7123358.23
经营活动现金流入小计(万元)155141.55601476.42454867.41294823.78146640.08
经营活动现金流出小计(万元)123214.32509863.77363748.14232640.08123281.85
投资活动产生的现金流量净额(万元)40619.05-141147.76-120664.57-94908.20-67352.19
投资活动现金流入小计(万元)229510.72624792.87472498.04248556.54101172.57
投资活动现金流出小计(万元)188891.66765940.63593162.61343464.73168524.75
筹资活动产生的现金流量净额(万元)-1239.82-30097.05-26569.79-30978.90195.10
筹资活动现金流入小计(万元)--16385.5916353.344975.822000.00
筹资活动现金流出小计(万元)1239.8246482.6442923.1335954.711804.90
期末现金及现金等价物余额(万元)192639.05121346.23144867.51137275.62157175.40
最后修改日期2025-04-212025-03-312024-10-292024-07-302024-04-20
↑返回页顶↑

转至恩华药业（002262）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。